| Cash Flow | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|
| Net income | 27,036 | 33,649 | 32,482 |
| Provision for credit loss expense | 998 | -15,495 | 24,350 |
| Depreciation and amortization of premises and equipment, operating leases assets, core deposit intangible, and mortgage servicing rights | 3,644 | 3,817 | 7,089 |
| Accretion of securities, deferred loan fees and costs, net yield and credit mark on acquired loans, and unearned income | 4,578 | 4,716 | 8,211 |
| Net amortization of deferred costs on borrowings | 76 | 76 | 228 |
| Deferred tax (benefit) expense | NaN | -5,068 | NaN |
| Net realized gains on sales of available-for-sale securities | 331 | 771 | 397 |
| Net realized and unrealized losses on equity securities | -89 | 280 | 982 |
| Gain on sale of loans held for sale | 356 | -992 | -262 |
| Net (gains) losses on dispositions of premises and equipment and foreclosed assets | -16 | 2 | 158 |
| Proceeds from sale of loans held for sale | 9,350 | 12,137 | 17,738 |
| Origination of loans held for sale | 7,778 | 13,722 | 17,293 |
| Income on bank owned life insurance | 986 | 2,239 | 2,531 |
| Gain on bank owned life insurance (death benefit proceeds in excess of cash surrender value) | NaN | -1,391 | 180 |
| Restricted stock compensation expense | 791 | 778 | 1,891 |
| Stock-based contribution expense | NaN | 0 | NaN |
| Accrued interest receivable and other assets | -3,779 | -9,637 | 7,831 |
| Accrued interest payable, lease liabilities, and other liabilities | -12,560 | -4,216 | -7,578 |
| Net cash provided by operating activities | 19,190 | 26,104 | 38,879 |
| Proceeds from maturities, prepayments and calls of available-for-sale securities | 27,875 | 36,192 | 90,044 |
| Proceeds from sales of available-for-sale securities | 36,670 | 82,671 | 258,295 |
| Proceeds from sale of equity securities | NaN | 0 | 1,164 |
| Purchase of available-for-sale securities | 179,896 | 167,665 | 168,155 |
| Proceeds from maturities, prepayments and calls of held-to-maturity securities | 17,129 | 7,303 | 57,574 |
| Purchase of equity securities | 128 | 80 | 231 |
| Proceeds from loans held for sale previously classified as portfolio loans | NaN | 47,785 | 23,215 |
| Net decrease (increase) in loans receivable | -63,252 | 48,340 | 227,654 |
| Proceeds from death benefit of bank owned life insurance policies | NaN | 1,587 | 884 |
| Net cash from business combinations | NaN | 0 | 27,403 |
| Purchase of fhlb, other equity, and restricted equity interests | 16,946 | -2,312 | -4,061 |
| Purchase of premises and equipment | 362 | 129 | 6,203 |
| Proceeds from the sale of premises and equipment and foreclosed assets | 57 | 3,922 | 1,689 |
| Purchase of other intangibles | NaN | 0 | NaN |
| Net cash used by investing activities | -52,349 | -34,442 | 62,086 |
| Net increase in checking, money market and savings accounts | 57,858 | 162,605 | 155,024 |
| Net increase in certificates of deposit | 55,309 | -40,474 | 10,904 |
| Net increase in deposits held for sale | 1,804 | NaN | NaN |
| Purchase of treasury stock | 542 | 0 | 333 |
| Cash dividends paid, common stock | 5,631 | 5,305 | 12,885 |
| Cash dividends paid, preferred stock | 1,075 | 1,076 | 3,226 |
| Net decrease in short-term borrowings | NaN | -17,604 | -255,396 |
| Net cash provided by financing activities | 107,723 | 98,146 | -105,912 |
| Net increase in cash and cash equivalents | 74,564 | 89,808 | -4,947 |
| Cash and cash equivalents, beginning | 527,896 | 4,947 | 443,035 |
| Cash and cash equivalents, ending | 602,460 | 89,808 | 438,088 |
CNB FINANCIAL CORP PA (CCNEP)
CNB FINANCIAL CORP PA (CCNEP)